| Examiner | Number of Cases | 3YGR |
|---|---|---|
| Examiner Alley | 390 | 56% |
| Examiner Azpuru | 540 | 86% |
| Examiner Boateng | 14 | 0% |
| Examiner Browe | 342 | 16% |
| Examiner Coniglio | 356 | 56% |
| Examiner Fay | 332 | 66% |
| Examiner Hagopian | 222 | 51% |
| Examiner Johnson | 273 | 40% |
| Examiner Justice | 374 | 58% |
| Examiner Meyers | 1 | 0% |
| Examiner Pallay | 346 | 52% |
| Examiner Peebles | 300 | 33% |
| Examiner Pipic | 370 | 52% |
| Art Unit 1617 | 3860 | 54% |
| Number | Class Description |
|---|---|
| 424 | Drug, bio-affecting and body treating compositions |
| 514 | Drug, bio-affecting and body treating compositions |
| 504 | Plant protecting and regulating compositions |
| 604 | Surgery |
| 623 | Prosthesis (i.e., artificial body members), parts thereof, or aids and accessories therefor |
| 606 | Surgery |
| 435 | Chemistry: molecular biology and microbiology |
| 600 | Surgery |
| 241 | Solid material comminution or disintegration |
| 264 | Plastic and nonmetallic article shaping or treating: processes |
Art Unit 1617's grant rate is higher than that of Group 1610 and lower than that of the USPTO.
Below is the grant rate timeline for Art Unit 1617, where the timeline is relative to the date of the first office action. The three-year grant rate is the percentage of applications granted at three years after the first office action.
Disclaimer: We do not provide any guarantees as to the accuracy of the statistics presented above and under
no circumstances will we be liable for any outcome resulting from your reliance on the above statistics.